Agila: the next billion dollar Indian acquisition in the works?
This article was originally published in Scrip
Executive Summary
Agila Specialties is perhaps the next big deal on the horizon in the Indian pharmaceutical industry despite the carefully worded denial by Strides Arcolab's top brass on plans to hawk the firm’s crown jewel and injectables arm.